Primary information |
---|
ID | 13594 |
Uniprot ID | Q9VT51 |
Description | Probable insulin-like peptide 2 (dILP2) (Insulin-related peptide 2) [Cleaved into- Probable insulin-like peptide 2 A chain; Probable insulin-like peptide 2 B chain] |
Organism | Drosophila melanogaster |
Txonomy | Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Protostomia; Ecdysozoa; Panarthropoda; Arthropoda; Mandibulata; Pancrustacea; Hexapoda; Insecta; Dicondylia; Pterygota (winged insects); Neoptera; Endopterygota; Diptera; Brachycera; Muscomorpha; Eremoneura; Cyclorrhapha; Schizophora; Acalyptratae; Ephydroidea; Drosophilidae (pomace flies); Drosophilinae; Drosophilini; Drosophila (fruit flies); Sophophora; melanogaster group; melanogaster subgroup; Drosophila melanogaster (Fruit fly) |
Subcellular Location | Secreted |
Developmental Stage | Expressed in the embryo and larva. |
Similarity | Belongs to the insulin family. |
Tissue Specificity | Broadly expressed at a low level in the embryonic mesoderm; beginning at stage 12. Expressed at a high level in the embryonic anterior midgut; with expression diminishing at late stage 16. Expressed a |
Post Translational Modification | NA |
Function | Plays a role in regulating body size by increasing cell size and cell number of individual organs. Probably mediates its growth effects by acting as a ligand for the insulin receptor and transducing a signal via the Chico/PI3K/Akt(PKB) pathway. |
Length | 137 |
Molecular Weight | 15 |
Name | Probable insulin-like peptide 2 |
Sequence | LCSEKLNEVLSMVCEEYNPVIPHKRAMPGADSDLDALNPLQFVQEFEEEDNSISEPLRSALFPGSYLGGVLNSLAEVRRRTRQRQGIVERCCKKSCDMKALREYCSVVRN |
Sequence map | 29-17 |
PDB ID | NA |
Drugpedia | NA |
Receptor | NA |
Domain | NA |
Pharmaceutical Use | NA
|